Cart 0
Targeted Treatment can Reduce Relapse in Children With Acute Myeloid Leukemia
In pediatric patients with acute myeloid leukemia (AML), the addition of a monoclonal antibody called gemtuzumab combined with standard chemotherapy
Adding {{itemName}} to cart
Added {{itemName}} to cart